UNSPSC 85816329: Introduction of immunosuppressive into peripheral vein, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of immunosuppressive into peripheral vein, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E033WL

UNSPSC 85816329, Introduction of immunosuppressive into peripheral vein, percutaneous approach, is a Commodity code that sits at odds with the recent state and local contract opportunities posted under it—the code appears to describe a specific clinical procedure, yet the recent solicitations tracked to it span virtual urgent care, medical services, PACE operations, cancer registry, retinal screening, EMS staffing, employee health clinics, occupational health, and wellness platforms, none of which directly align with intravenous immunosuppressive drug administration. The mismatch signals that this Commodity code either has been misapplied to a broad family of healthcare service procurements or reflects a tagging error in the source data. State and local buyers appear to be using this code as a catch-all for health services rather than for the discrete clinical procedure the code nominally describes.

The issuing bodies span health authorities (Nevada Health Authority), county health systems (Santa Clara, San Mateo, Brevard, Forsyth, Seminole, Sarasota, Cobb, DeKalb), city departments (Ocala, Phoenix, Fairfax, Atlanta, Boulder, Rockland), school districts (Parkway), special districts (Inland Empire Health Plan, Sourcewell), and state agencies (Colorado Department of Human Services, Texas Health and Human Services Commission, Illinois Secretary of State, New Jersey Department of Health). Geographic activity concentrates in California (seven opportunities), Nevada, Texas, Colorado, Kansas, Georgia, and Florida, with secondary presence in New York, Illinois, Oregon, Arizona, and the District of Columbia. Recent representative solicitations include Inland Empire Health Plan's RFI for 24/7 virtual urgent care services with a response deadline of October 31, 2026; the Nevada Health Authority's RFP for Program of All Inclusive Care for the Elderly (PACE) with proposals due December 10, 2026; and San Mateo County's RFP for cancer registry services with proposals due November 6, 2026—all issued between August and October 2026. The code shows no coherent market signal; the misalignment between its procedural title and the scope of actual solicitations makes it difficult to assess whether this represents genuine procurement activity in immunosuppressive drug administration or simply classification error masking a broader healthcare services category.